Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3362418 | International Journal of Infectious Diseases | 2014 | 4 Pages |
Abstract
SummaryA case of primary Epstein–Barr virus (EBV) infection/parvovirus B19 reactivation fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis (HLH) is presented. Despite two coinciding viral infections, massive splenomegaly, and fulminant hepatitis, the patient had a good clinical outcome, probably due to an early onset form of HLH with normal leukocyte count, normal natural killer (NK) cell function, and a lack of hemophagocytosis.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Matthias Karrasch, Jörg Felber, Peter M. Keller, Christine Kletta, Renate Egerer, Jürgen Bohnert, Beate Hermann, Wolfgang Pfister, Bernhard Theis, Iver Petersen, Andreas Stallmach, Michael Baier,